Industry News Roundup
This article was originally published in The Tan Sheet
Executive Summary
Nexium 24HR Sample Pack Approved; Boots Protection Claims Imply Prevention; Support of Philosophy serum is “inherently arbitrary,” NAD said; Nestle Formula Comparative Claims Apply Across Entire Category; Happy consumers OK for U.K. e-cig ads; Manzo Scouts Probiotic Path At FDA and Ingredion acquires Penford.
You may also be interested in...
FTC Requests Drug Claim Support For Bayer Probiotic Supplement
On behalf of the FTC, DoJ alleges Bayer violated a 2007 settlement to substantiate supplement claims and asks a court to require the firm to provide two RCTs for dietary supplement claims for Phillips’ Colon Health. Trade groups rally behind the firm, arguing the requirement is unfair and illegal.
In Brief: Vitamix Expands, No “Probiotic” In E.U. Ads, Mylan Misses On Meda, Akorn Hits On VersaPharm
Vitamix triples manufacturing space; using ‘probiotic’ not allowed in E.U.; Meda rejects Mylan bids; Akorn acquires VersaPharm; La. blocks DXM sales to minors; and more news In Brief.
MedVantx Automates OTC Drug Sampling At Point Of Care
Procter & Gamble'sPrilosec OTC will be one of the first nonprescription drugs to be offered through automated "Sample Centers"- ATM-like dispensers placed in physicians' offices - as part of the MedVantx OTC Advantage program